Xi'an Watson Biology Technology Co., Ltd, headquartered in Xi'an Hi-tech industrial development zone, with a registered capital of RMB 32.5 million, was launched by Ms. Cao Shengyu and other 8 natural persons, and was approved by Xi??n Municipal Government in December, 2002. Watson Bio, a cross-industrial, cross-regional, and multi-ownership Hi-tech corporation. It integrates R&D, production, and marketing in one corporation. The company is mainly engaged in the extracting and processing of cancer-resistant TAXOL, and taxus planting and TAXOL bio-product processing, as well as related international business. Since its establishment, Watson Bio has held top-ranking platforms in human genetic analysis and research throughout the world, and has established a key laboratory in cooperation with the Genetic Diagnosis Tech Research Institute of the Fourth Military Medical University. With the largest taxus planting base in China, now it is the largest producer and exporter of TAXOL. The complete production chains make Watson Bio a pioneer in R&D of genetic biology and make it easier for the company to develop steadily at relatively low cost. By sticking to the ideology---Glorify the prestige of Chinese medicine, and forge a magnate of Genetic technology all the time, and relying upon its abundant science and technology strength and advanced management experience, Watson Bio has intensified its competitive power enormously. With the execution of the Outline of National Mid-term and Long-term Program for Development of Science and Technology, Watson Bio will continue to probe into the research of modern Chinese medicine as usual and develop productive technologies, strengthen the research and protection of intellectual property rights, and facilitate the establishment of international cooperation platforms. Watson Bio is adapting itself to economic globalization and establishing itself as a highly competitive corporation by referring to international experience.
